Nemaura Medical Inc. (NMRD)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.14 Million USD | -80.78% |
| 2022 | -13.88 Million USD | -121.88% |
| 2021 | -6.25 Million USD | -50.44% |
| 2020 | -4.16 Million USD | 6.57% |
| 2019 | -4.45 Million USD | -144.6% |
| 2018 | -1.82 Million USD | -17.35% |
| 2017 | -1.55 Million USD | -0.76% |
| 2016 | -1.53 Million USD | -16.65% |
| 2015 | -1.31 Million USD | -125.14% |
| 2014 | -586.23 Thousand USD | 29.42% |
| 2013 | -830.57 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.6 Million USD | -692.48% |
| 2024 Q3 | -2.16 Million USD | -79.61% |
| 2024 Q2 | -1.2 Million USD | 53.77% |
| 2023 Q2 | -3.85 Million USD | 32.92% |
| 2023 FY | -25.1 Million USD | -80.78% |
| 2023 Q4 | -328.48 Thousand USD | 88.27% |
| 2023 Q3 | -2.79 Million USD | 27.4% |
| 2023 Q1 | -5.74 Million USD | -4.65% |
| 2022 Q4 | -5.49 Million USD | -60.06% |
| 2022 Q1 | -3.34 Million USD | -56.94% |
| 2022 Q2 | -3.49 Million USD | -4.5% |
| 2022 Q3 | -3.43 Million USD | 1.79% |
| 2022 FY | -13.88 Million USD | -121.88% |
| 2021 Q3 | -1.44 Million USD | 8.51% |
| 2021 FY | -6.25 Million USD | -50.44% |
| 2021 Q4 | -2.13 Million USD | -47.28% |
| 2021 Q1 | -1.1 Million USD | 18.33% |
| 2021 Q2 | -1.58 Million USD | -43.74% |
| 2020 Q2 | -1.11 Million USD | 10.73% |
| 2020 Q1 | -1.25 Million USD | 22.97% |
| 2020 FY | -4.16 Million USD | 6.57% |
| 2020 Q4 | -1.34 Million USD | -202.67% |
| 2020 Q3 | -445 Thousand USD | 60.16% |
| 2019 Q1 | -763.15 Thousand USD | -37.94% |
| 2019 FY | -4.45 Million USD | -144.6% |
| 2019 Q4 | -1.62 Million USD | -75.45% |
| 2019 Q3 | -925.88 Thousand USD | 18.73% |
| 2019 Q2 | -1.13 Million USD | -49.29% |
| 2018 Q4 | -553.26 Thousand USD | -18.63% |
| 2018 Q3 | -466.36 Thousand USD | -18.66% |
| 2018 Q2 | -393.03 Thousand USD | 3.62% |
| 2018 Q1 | -407.78 Thousand USD | -13.52% |
| 2018 FY | -1.82 Million USD | -17.35% |
| 2017 FY | -1.55 Million USD | -0.76% |
| 2017 Q4 | -359.23 Thousand USD | 4.3% |
| 2017 Q3 | -375.36 Thousand USD | -16.4% |
| 2017 Q2 | -322.48 Thousand USD | 34.74% |
| 2017 Q1 | -494.18 Thousand USD | -18.31% |
| 2016 Q1 | -402.82 Thousand USD | 24.84% |
| 2016 FY | -1.53 Million USD | -16.65% |
| 2016 Q4 | -417.71 Thousand USD | -27.05% |
| 2016 Q3 | -328.78 Thousand USD | 15.76% |
| 2016 Q2 | -390.3 Thousand USD | 3.11% |
| 2015 Q4 | -535.93 Thousand USD | -237.57% |
| 2015 FY | -1.31 Million USD | -125.14% |
| 2015 Q1 | -269.25 Thousand USD | -66.07% |
| 2015 Q2 | -355.88 Thousand USD | -32.18% |
| 2015 Q3 | -158.76 Thousand USD | 55.39% |
| 2014 Q1 | -61.77 Thousand USD | 70.25% |
| 2014 Q3 | -340.19 Thousand USD | -1437.12% |
| 2014 Q4 | -162.12 Thousand USD | 52.34% |
| 2014 FY | -586.23 Thousand USD | 29.42% |
| 2014 Q2 | -22.13 Thousand USD | 64.17% |
| 2013 Q4 | -207.64 Thousand USD | 0.0% |
| 2013 FY | -830.57 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 82.68% |
| Biotricity, Inc. | -14.09 Million USD | -0.351% |
| Cell MedX Corp. | -142.48 Thousand USD | -9826.403% |
| Dynatronics Corporation | -2.69 Million USD | -424.285% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -29.104% |
| RetinalGenix Technologies Inc. | -2.09 Million USD | -576.446% |
| Sonendo, Inc. | -60.91 Million USD | 76.783% |
| Telesis Bio, Inc. | -47.72 Million USD | 70.363% |
| Talis Biomedical Corporation | -62 Million USD | 77.19% |
| Viveve Medical, Inc. | -22.02 Million USD | 35.789% |